The IL-6—STAT3 signalling axis has emerged as a key contributor to carcinogenesis in a number of cancers [21], often resulting in increased IL-6 expression as observed in lung cancer and head and neck cancers [58,59]. This evidence concerns the gene STAT3 and lung cancer.